UNSPSC 51362801: Methaqualone

This classification denotes a sedative and hypnotic with the molecular formula C16H14N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7ZKH8MQW6T, chemically known as 3,4-dihydro-2-methyl-4-oxo-3-o-tolylquinazoline but generally known as methaqualone, which bears US NIH Compound Identifier 6292. European Medicines Agency schedules Methaqualone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08840MIG.

UNSPSC 51362801 Methaqualone is a Commodity code that in practice does not reflect state and local procurement activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems for community health initiatives, a scope unrelated to the code's nominal pharmaceutical substance classification. The mismatch between code and actual procurement suggests either a data-entry error in the opportunity record or a misalignment between the state and local tagging taxonomy and the procurement's actual product line. The Seminole County IFB called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, on a fixed-fee basis with an initial two-year term and one-year renewal option, but no further state or local opportunities appear under this code in the recent dataset.

Given the absence of relevant recent activity and the plain disconnect between the code's definition and the single opportunity posted, the code does not represent an active or reliable procurement avenue for business development purposes. Any vendor interested in naloxone or drug deactivation system procurement should monitor county health department and emergency management RFPs separately, rather than track this UNSPSC code as a sourcing signal.